Ultrafast 30-min infusion of a rituximab biosimilar (Truxima)

EJHAEM(2023)

引用 0|浏览6
暂无评分
摘要
In this clinical trial, we demonstrate that ultrarapid fast infusion of rituximab (Truxima) in 30 min with oral premedication is feasible and secure for patients, and reduce the day-care hospital stays.
更多
查看译文
关键词
rituximab,ultrafast infusion,cost-efective
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要